发明公开
EP2137175A1 NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME
有权
基于菲和药物组合物新的连接，以用于治疗或 预防与关联STOFFWECHSELSYSNDROM疾病的
- 专利标题： NOVEL PHENANTHRENEQUINONE-BASED COMPOUND AND PHARMACEUTICAL COMPOSITION CONTAINING THE SAME FOR THE TREATMENT OR PREVENTION OF DISEASE INVOLVING METABOLIC SYNDROME
- 专利标题（中）： 基于菲和药物组合物新的连接，以用于治疗或 预防与关联STOFFWECHSELSYSNDROM疾病的
-
申请号： EP08741558.4申请日： 2008-04-25
-
公开(公告)号： EP2137175A1公开(公告)日： 2009-12-30
- 发明人: YOO, Sang-Ku , KANG, Ku Suk , YOO, Sang Woo , KWAK, Taehwan
- 申请人： Mazence Inc. , KT & G Co., Ltd.
- 申请人地址： No 217, Taesan-Sigma Ville, 936 Dunsan-dong, Seo-gu Daejeon 302-120 KR
- 专利权人： Mazence Inc.,KT & G Co., Ltd.
- 当前专利权人： Mazence Inc.,KT & G Co., Ltd.
- 当前专利权人地址： No 217, Taesan-Sigma Ville, 936 Dunsan-dong, Seo-gu Daejeon 302-120 KR
- 代理机构： HOFFMANN EITLE
- 优先权： KR20070040673 20070426
- 国际公布： WO2008133441 20081106
- 主分类号： C07D307/77
- IPC分类号： C07D307/77
摘要：
Provided is a pharmaceutical composition for the treatment and/or prevention of disease involving metabolic syndromes, comprising (a) a therapeutically effective amount of a particular compound represented by Formula 1 as defined in the specification, or isomer, prodrug, or solvate or thereof, and (b) a pharmaceutically acceptable carrier, a diluent or an excipient, or any combination thereof.
公开/授权文献
信息查询
